Abbott's $5.8 Billion Deal for Alere Is Device Sector's Latest

  • Stryker, Medtronic also announced medical device deals Monday
  • CEO says Abbott has appetite for acquisitions in other areas

Abbott Agrees to Buy Alere for $5.8 Billion

Abbott Laboratories agreed to buy Alere Inc. for $56 a share, or about $5.8 billion, to become the leader in the market for rapid medical tests and adding another deal to a long list in the fast-consolidating medical devices and technology space.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.